Evonik Industries (FRA:EVK) has been given a €35.00 ($43.21) price objective by equities researchers at Sanford C. Bernstein in a report issued on Monday. The firm presently has a “buy” rating on the stock. Sanford C. Bernstein’s target price would indicate a potential upside of 21.82% from the stock’s current price.
EVK has been the topic of several other reports. JPMorgan Chase & Co. set a €25.00 ($30.86) price objective on Evonik Industries and gave the stock a “sell” rating in a research note on Wednesday, January 17th. Deutsche Bank set a €40.00 ($49.38) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Monday, December 4th. UBS Group set a €27.00 ($33.33) price objective on Evonik Industries and gave the stock a “sell” rating in a research note on Monday, January 22nd. Baader Bank set a €38.00 ($46.91) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Thursday, March 1st. Finally, Berenberg Bank set a €37.00 ($45.68) price objective on Evonik Industries and gave the stock a “buy” rating in a research note on Thursday. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Hold” and an average price target of €33.74 ($41.65).
Evonik Industries (EVK) traded down €0.11 ($0.14) during mid-day trading on Monday, hitting €28.73 ($35.47). 538,521 shares of the stock were exchanged. Evonik Industries has a twelve month low of €26.78 ($33.06) and a twelve month high of €32.97 ($40.70). The firm has a market capitalization of $13,430.00 and a P/E ratio of 18.66.
WARNING: “Evonik Industries (EVK) PT Set at €35.00 by Sanford C. Bernstein” was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/03/12/evonik-industries-evk-pt-set-at-35-00-by-sanford-c-bernstein.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.